Theriva Biologics, Inc. (TOVX)
0.2468
-0.01
(-2.26%)
USD |
NYAM |
Aug 28, 15:42
Theriva Biologics Cash from Operations (Quarterly) : -3.085M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.085M |
| March 31, 2026 | -2.456M |
| December 31, 2025 | -2.882M |
| September 30, 2025 | -4.319M |
| June 30, 2025 | -4.712M |
| March 31, 2025 | -4.756M |
| December 31, 2024 | -4.691M |
| September 30, 2024 | -3.913M |
| June 30, 2024 | -3.452M |
| March 31, 2024 | -4.881M |
| December 31, 2023 | -6.541M |
| September 30, 2023 | -2.953M |
| June 30, 2023 | -3.892M |
| March 31, 2023 | -5.61M |
| December 31, 2022 | -5.368M |
| September 30, 2022 | -4.456M |
| June 30, 2022 | -4.356M |
| March 31, 2022 | -4.902M |
| December 31, 2021 | -4.81M |
| September 30, 2021 | -2.156M |
| June 30, 2021 | -2.596M |
| March 31, 2021 | -3.328M |
| December 31, 2020 | -3.132M |
| September 30, 2020 | -2.05M |
| June 30, 2020 | -2.026M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.96M |
| December 31, 2019 | -3.605M |
| September 30, 2019 | -3.062M |
| June 30, 2019 | -2.982M |
| March 31, 2019 | -4.224M |
| December 31, 2018 | -3.29M |
| September 30, 2018 | -3.602M |
| June 30, 2018 | -4.308M |
| March 31, 2018 | -6.079M |
| December 31, 2017 | -3.932M |
| September 30, 2017 | -4.524M |
| June 30, 2017 | -5.74M |
| March 31, 2017 | -6.008M |
| December 31, 2016 | -10.38M |
| September 30, 2016 | -5.983M |
| June 30, 2016 | -5.86M |
| March 31, 2016 | -5.674M |
| December 31, 2015 | -10.97M |
| September 30, 2015 | -15.21M |
| June 30, 2015 | -7.25M |
| March 31, 2015 | -5.458M |
| December 31, 2014 | -4.779M |
| September 30, 2014 | -4.535M |
| June 30, 2014 | -3.295M |
| March 31, 2014 | -3.47M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Nkarta, Inc. | -24.22M |
| Unicycive Therapeutics, Inc. | -7.604M |
| OnKure Therapeutics, Inc. | -10.35M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.003M |
| Cash from Financing (Quarterly) | -0.014M |
| Free Cash Flow | -12.76M |
| Free Cash Flow Per Share (Quarterly) | -0.0673 |
| Free Cash Flow to Equity (Quarterly) | -2.948M |
| Free Cash Flow to Firm (Quarterly) | -3.088M |
| Free Cash Flow Yield | -156.3% |